Process View
A cell cycle checkpoint that detects and negatively regulates progression from G1 to S phase as part of a mitotic cell cycle.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "mitotic g1 s transition checkpoint"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.996 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.976 | ||
| RB1 | retinoblastoma 1 | 0.960 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.923 | ||
| CASP2 | caspase 2, apoptosis-related cysteine peptidase | 0.829 | ||
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.811 | Human | |
| TP53 | tumor protein p53 | 0.641 | ||
| APAF1 | apoptotic peptidase activating factor 1 | 0.617 | ||
| PPP2R1B | protein phosphatase 2, regulatory subunit A, beta | 0.550 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.493 | ||
| CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 0.441 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.438 | Human | |
| RPA1 | replication protein A1, 70kDa | 0.437 | ||
| CHEK2 | CHK2 checkpoint homolog (S. pombe) | 0.376 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.376 | ||
| CCND3 | cyclin D3 | 0.369 | Human | |
| PPP2CA | protein phosphatase 2, catalytic subunit, alpha isozyme | 0.287 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.265 | ||
| LRDD | leucine-rich repeats and death domain containing | 0.259 | ||
| CCND1 | cyclin D1 | 0.245 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.226 | ||
| IER3 | immediate early response 3 | 0.215 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.198 | ||
| PPP2R5C | protein phosphatase 2, regulatory subunit B', gamma | 0.191 | ||
| CDK2 | cyclin-dependent kinase 2 | 0.190 | ||
| CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 0.186 | Human | |
| PCGF2 | polycomb group ring finger 2 | 0.180 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.147 | Human | |
| WWOX | WW domain containing oxidoreductase | 0.144 | ||
| PPP2R2A | protein phosphatase 2, regulatory subunit B, alpha | 0.142 | ||
| POU5F1 | POU class 5 homeobox 1 | 0.110 | ||
| PPP2R5A | protein phosphatase 2, regulatory subunit B', alpha | 0.109 | Human | |
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.095 | ||
| USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | 0.093 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.083 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.079 | ||
| POU3F2 | POU class 3 homeobox 2 | 0.066 | ||
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.064 | ||
| SKP2 | S-phase kinase-associated protein 2 (p45) | 0.053 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.053 | ||
| PAX3 | paired box 3 | 0.047 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.046 | ||
| RBL2 | retinoblastoma-like 2 (p130) | 0.044 | ||
| ARRB2 | arrestin, beta 2 | 0.043 | ||
| PRNP | prion protein | 0.039 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.038 | ||
| BRCA1 | breast cancer 1, early onset | 0.037 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.037 | ||
| BIRC2 | baculoviral IAP repeat containing 2 | 0.034 | ||
| UBR3 | ubiquitin protein ligase E3 component n-recognin 3 (putative) | 0.033 | ||
| FOXD3 | forkhead box D3 | 0.033 | ||
| SKP1 | S-phase kinase-associated protein 1 | 0.033 | ||
| MKRN1 | makorin ring finger protein 1 | 0.033 | ||
| SMAD7 | SMAD family member 7 | 0.030 | ||
| DAXX | death-domain associated protein | 0.030 | ||
| CCND2 | cyclin D2 | 0.030 | Human | |
| RBL1 | retinoblastoma-like 1 (p107) | 0.029 | ||
| GADD45A | growth arrest and DNA-damage-inducible, alpha | 0.027 | ||
| GNL3L | guanine nucleotide binding protein-like 3 (nucleolar)-like | 0.027 | ||
| PPFIA1 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 | 0.026 | ||
| CBLC | Cas-Br-M (murine) ecotropic retroviral transforming sequence c | 0.022 | ||
| CCNE1 | cyclin E1 | 0.022 | ||
| KRT5 | keratin 5 | 0.021 | ||
| MED1 | mediator complex subunit 1 | 0.021 | ||
| NOTCH1 | notch 1 | 0.020 | ||
| NUCB2 | nucleobindin 2 | 0.020 | ||
| SPRR2A | small proline-rich protein 2A | 0.020 | ||
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.019 | Human | |
| GORAB | golgin, RAB6-interacting | 0.018 | ||
| RYBP | RING1 and YY1 binding protein | 0.018 | ||
| CCNA1 | cyclin A1 | 0.018 | ||
| PIM1 | pim-1 oncogene | 0.018 | ||
| DIABLO | diablo, IAP-binding mitochondrial protein | 0.017 | ||
| CSNK1A1 | casein kinase 1, alpha 1 | 0.016 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.016 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.015 | ||
| CABLES1 | Cdk5 and Abl enzyme substrate 1 | 0.014 | ||
| SGK3 | serum/glucocorticoid regulated kinase family, member 3 | 0.014 | ||
| RASSF1 | Ras association (RalGDS/AF-6) domain family member 1 | 0.014 | ||
| MARCKSL1 | MARCKS-like 1 | 0.014 | ||
| SATB2 | SATB homeobox 2 | 0.014 | ||
| YAP1 | Yes-associated protein 1 | 0.014 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.013 | ||
| ELF4 | E74-like factor 4 (ets domain transcription factor) | 0.013 | ||
| SMPD1 | sphingomyelin phosphodiesterase 1, acid lysosomal | 0.013 | ||
| RIOK3 | RIO kinase 3 (yeast) | 0.013 | ||
| SLC9A3R2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | 0.013 | ||
| MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.012 | Human | |
| RPS27L | ribosomal protein S27-like | 0.012 | ||
| UNG | uracil-DNA glycosylase | 0.011 | ||
| E2F3 | E2F transcription factor 3 | 0.011 | ||
| SALL2 | sal-like 2 (Drosophila) | 0.011 | ||
| DZIP1 | DAZ interacting protein 1 | 0.011 | ||
| PML | promyelocytic leukemia | 0.011 | Mouse | |
| CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | 0.010 | ||
| CDK14 | cyclin-dependent kinase 14 | 0.010 |